Drug induced secondary angle closure glaucoma- A case series
Panacea Journal of Medical Sciences · 28.11.2022 · 12 (3) · 724-726
DOI: 10.18231/j.pjms.2022.134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Panacea Journal of Medical Sciences, online erschienen am 28.11.2022. Verfasst von Saranya Balakrishnan und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
We report 3 cases with acute bilateral angle closure glaucoma following intake of oral chlorthalidone, mefenamic acid, topiramate.Materials and Methods: Case series.
Results
All patients developed bilateral acute onset painful defective vision with shallow anterior chamber, raised intraocular pressure. Gonioscopy revealed bilateral occludable angle and ultrasonogram B scan showed shallow choroidal detachment, suggestive of drug induced non pupillary block secondary angle closure glaucoma. All patients were managed by discontinuation of causative drug and started on topical antiglaucoma medication and cycloplegic drug.
Conclusion
We would like to bring this potentially sight threatening and reversible ophthalmic condition to general physician, which can be managed effectively by timely referral and intervention.
Zitieren
APA
Balakrishnan, S., Anandan, A. M., & Arunachalasamy, C. (2022). Drug induced secondary angle closure glaucoma- A case series. Panacea Journal of Medical Sciences, 12(3), 724-726. https://doi.org/10.18231/j.pjms.2022.134
Vancouver
Balakrishnan S, Anandan AM, Arunachalasamy C. Drug induced secondary angle closure glaucoma- A case series. Panacea Journal of Medical Sciences. 2022;12(3):724-726. doi:10.18231/j.pjms.2022.134
BibTeX
@article{Balakrishnan2022,
author = {Balakrishnan, Saranya and Anandan, Amrutha Mahalakshmi and Arunachalasamy, Chandrika},
title = {Drug induced secondary angle closure glaucoma- A case series},
journal = {Panacea Journal of Medical Sciences},
year = {2022},
volume = {12},
number = {3},
pages = {724--726},
doi = {10.18231/j.pjms.2022.134}
}
EUVIMED